Pfizer To Seek Nod For Malaria Drug Trials

Pfizer will soon be seeking permission from the health ministry to conduct clinical trials in India on a new drug combination for malaria.

The company plans to test the combination of its product azithromycin, an antibiotic, with chloroquine as a treatment for the disease.